ESR1 and breast carcinoma: We have previously shown in estrogen receptor (ER)-positive breast cancer cell lines that IGF-I promoted lipogenesis by reducing the association between BRCA1 and the inactive, phosphorylated form of ACCA, resulting in de-phosphorylation of the enzyme [16].